Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Warner

Showing results (61-70 of 159) with videos related to

Pageof 16
Sort By:
Radiation Oncology (London, England)|March 22, 2018
A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinomaRohann J M Correa, Belal Ahmad, Andrew Warner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2013
Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcsEva M Bongers, Angela Botticella, David A Palma, et al.
European Urology Oncology|October 25, 2022
Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary CancersMai Anh Huynh, Chad Tang, Shankar Siva, et al.
Radiation Oncology (London, England)|July 6, 2018
Evaluation of a new predictor of heart and left anterior descending artery dose in patients treated with adjuvant radiotherapy to the left breastLucas C Mendez, Alexander V Louie, Carolina Moreno, et al.
Journal of Medical Imaging and Radiation Oncology|October 4, 2018
Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid <sup>18</sup> F-fluorodeoxyglucose-positron emission tomography and CT perfusion studyDae-Myoung Yang, David Palma, Alexander Louie, et al.
BMC Palliative Care|April 6, 2025
Radiation-before-pathology approach in the palliative oncology setting: a pragmatic clinical trial protocol (RT-NOW)Sympascho Young, Melissa O'Neil, Joanna M Laba, et al.
Lung Cancer (Amsterdam, Netherlands)|February 6, 2022
Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot studyDaniel A Breadner, Mark D Vincent, Rohann Correa, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2015
Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysisGraham D Smith, Tom Pickles, Juanita Crook, et al.
Clinical Lung Cancer|May 16, 2018
SUNSET: Stereotactic Radiation for Ultracentral Non-Small-Cell Lung Cancer-A Safety and Efficacy TrialMeredith Giuliani, Ashwathy S Mathew, Houda Bahig, et al.
Journal of the National Cancer Institute|February 21, 2025
Effects of a high-fiber, high-fruit and high-vegetable, low-fat dietary intervention on the rectal tissue microbiomeDoratha A Byrd, Maria Gomez, Stephanie Hogue, et al.
Pageof 16

Showing results (61-70 of 159) with videos related to

Sort By:
Pageof 16
Radiation Oncology (London, England)|March 22, 2018
A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinomaRohann J M Correa, Belal Ahmad, Andrew Warner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2013
Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcsEva M Bongers, Angela Botticella, David A Palma, et al.
European Urology Oncology|October 25, 2022
Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary CancersMai Anh Huynh, Chad Tang, Shankar Siva, et al.
Radiation Oncology (London, England)|July 6, 2018
Evaluation of a new predictor of heart and left anterior descending artery dose in patients treated with adjuvant radiotherapy to the left breastLucas C Mendez, Alexander V Louie, Carolina Moreno, et al.
Journal of Medical Imaging and Radiation Oncology|October 4, 2018
Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid <sup>18</sup> F-fluorodeoxyglucose-positron emission tomography and CT perfusion studyDae-Myoung Yang, David Palma, Alexander Louie, et al.
BMC Palliative Care|April 6, 2025
Radiation-before-pathology approach in the palliative oncology setting: a pragmatic clinical trial protocol (RT-NOW)Sympascho Young, Melissa O'Neil, Joanna M Laba, et al.
Lung Cancer (Amsterdam, Netherlands)|February 6, 2022
Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot studyDaniel A Breadner, Mark D Vincent, Rohann Correa, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2015
Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysisGraham D Smith, Tom Pickles, Juanita Crook, et al.
Clinical Lung Cancer|May 16, 2018
SUNSET: Stereotactic Radiation for Ultracentral Non-Small-Cell Lung Cancer-A Safety and Efficacy TrialMeredith Giuliani, Ashwathy S Mathew, Houda Bahig, et al.
Journal of the National Cancer Institute|February 21, 2025
Effects of a high-fiber, high-fruit and high-vegetable, low-fat dietary intervention on the rectal tissue microbiomeDoratha A Byrd, Maria Gomez, Stephanie Hogue, et al.
Pageof 16